Hinova Pharmaceuticals Inc.
Clinical trials sponsored by Hinova Pharmaceuticals Inc., explained in plain language.
-
New pill shows promise against tough prostate cancer in early trial
Disease control Recruiting nowThis study tests an experimental daily pill called HP518 in men with metastatic castration-resistant prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to check the drug's safety, find the best dose, and see if it can shrink tumors or …
Phase: PHASE1, PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 14:00 UTC
-
New pill aims to melt liver fat in 12 weeks
Disease control Recruiting nowThis study tests an experimental pill, HP515, in 80 adults with non-alcoholic fatty liver disease (NAFLD). The main goal is to see if it reduces liver fat over 12 weeks using MRI scans. Participants must have at least 10% liver fat and be aged 18-65. The trial also checks safety …
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC